Business / Finance

RSS
ImmunoGen signs new license agreement with Novartis

ImmunoGen signs new license agreement with Novartis

Welichem Biotech announces results of substantial issuer bid

Welichem Biotech announces results of substantial issuer bid

KFx Medical Corporation receives $29M in patent infringement case against Arthrex Inc.

KFx Medical Corporation receives $29M in patent infringement case against Arthrex Inc.

Paragon BioTeck, Horus Pharma sign distribution agreement for Ilast range of products

Paragon BioTeck, Horus Pharma sign distribution agreement for Ilast range of products

Lakewood-Amedex, Wainwright enter into strategic advisory agreement

Lakewood-Amedex, Wainwright enter into strategic advisory agreement

Iscreen Vision raises $4.0 million in series B funding round

Iscreen Vision raises $4.0 million in series B funding round

Indutrade signs agreement to acquire all shares in Medexa Diagnostisk Service

Indutrade signs agreement to acquire all shares in Medexa Diagnostisk Service

Proveca signs agreement with EMA to develop Glycopyrronium drug for children with sialorrhoea

Proveca signs agreement with EMA to develop Glycopyrronium drug for children with sialorrhoea

Molecular Templates secures $8.5M series C financing plus $10.6M grant from CPRIT

Molecular Templates secures $8.5M series C financing plus $10.6M grant from CPRIT

Janssen buys all rights from GSK to develop, commercialize hepatitis C compound

Janssen buys all rights from GSK to develop, commercialize hepatitis C compound

Anesthesia Business Consultants unveils newest tool, F1RSTAnalytics at ASA Annual Convention

Anesthesia Business Consultants unveils newest tool, F1RSTAnalytics at ASA Annual Convention

AquaBased introduces new eco-friendly water-based adhesive for plastic-to-plastic bonding

AquaBased introduces new eco-friendly water-based adhesive for plastic-to-plastic bonding

NeuroVigil opens satellite research lab at NASA to develop assistive technologies for ALS

NeuroVigil opens satellite research lab at NASA to develop assistive technologies for ALS

Software crash in first days viewed as root cause of exchange delays

Software crash in first days viewed as root cause of exchange delays

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.